Amanta Healthcare shares list at 7% premium over IPO price
[hfe_template id='11223']
[ad_1]
Shares of Amanta Healthcare, a manufacturer of sterile liquid pharmaceuticals and medical devices, listed at a premium of 7% on the exchanges on Tuesday. The stock debuted at Rs 135 on the NSE and Rs 134 on the BSE (6.3% premium) against the issue price of Rs 126. The Rs 126 crore IPO was entirely a fresh issue of one crore equity shares. The fresh capital will primarily fund expansion. Approximately Rs 70 crore is earmarked for a new SteriPort manufacturing line at Hariyala, Gujarat, while Rs 30 crore will be allocated to set up another line for small-volume parenterals (SVPs). The remainder will go toward general corporate purposes. The IPO was open for subscription between September 1 and September 3, with allotment finalized on September 4. Beeline Capital Advisors served as the book-running lead manager, while MUFG Intime India handled registrar responsibilities. The offering received strong demand, with retail, non-institutional, an...